Financials
Financial year 2025
ExMediKA from Gesves, company number BE0785643679, closed financial year 2025 with a result of € 94,786 after tax. For that financial year ExMediKA recorded a gross margin of € 134,012 and equity of € 275,693. Compared with financial year 2024, the result moved from € 94,171 to € 94,786. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.
€ 275,693
▲ 52% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 94,786
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 83,262
▼ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 270,693.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 25,620
▲ 45% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,534
▼ 59% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 117,673 | € 134,327 | € 134,012 | |
| Profit after taxes | € 81,736 | € 94,171 | € 94,786 | ▲ 1% |
| Equity | € 86,736 | € 180,907 | € 275,693 | ▲ 52% |
| Total debts | € 71,679 | € 96,502 | € 106,875 | ▲ 11% |
| Cash | € 132,773 | € 95,931 | € 83,262 | ▼ 13% |
| Retained profit | € 81,736 | € 175,907 | € 270,693 | ▲ 54% |
| Balance sheet total | € 158,415 | € 277,409 | € 382,568 | ▲ 38% |
Key figures of ExMediKA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to ExMediKA?
What happened at ExMediKA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 94,786 (▲ 1% vs 2024). Source: NBB ↗
- New establishment in Gesves. KBO
- Karl Richir became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 81,736 profit in 2023 to € 94,786 profit in 2025.
Paid € 111,063 in corporate taxes since 2023.
Best year ever: 2025, with € 94,786 profit.
Management
Behind ExMediKA is Karl Richir.
Directors
According to the 2025 annual accounts
Karl Richir
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Drève des Arches 17
5340 Gesves
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0785.643.679
- VAT number
- BE 0785.643.679
- Registered office
- Drève des Arches 17, 5340 Gesves
- Names & denominations
- ExMediKA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 May 2022
- Peppol
- Active · Active since 28 Nov 2025
- Contact
- [email protected] +32497592112
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overige niet-gespecialiseerde detailhandel
Detailhandel in souvenirs en religieuze artikelen
Detailhandel via postorderbedrijven of via internet
Detailhandel in souvenirs en religieuze artikelen in gespecialiseerde winkels
Detailhandel in niet-gespecialiseerde winkels waarbij voedings- en genotmiddelen niet overheersen (verkoopoppervlakte < 2500 m²)